Cargando…
Antifungal Drug Repurposing
Control of fungal pathogens is increasingly problematic due to the limited number of effective drugs available for antifungal therapy. Conventional antifungal drugs could also trigger human cytotoxicity associated with the kidneys and liver, including the generation of reactive oxygen species. Moreo...
Autores principales: | Kim, Jong H., Cheng, Luisa W., Chan, Kathleen L., Tam, Christina C., Mahoney, Noreen, Friedman, Mendel, Shilman, Mikhail Martchenko, Land, Kirkwood M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697925/ https://www.ncbi.nlm.nih.gov/pubmed/33203147 http://dx.doi.org/10.3390/antibiotics9110812 |
Ejemplares similares
-
Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2022) -
High Efficiency Drug Repurposing Design for New Antifungal Agents
por: Kim, Jong H., et al.
Publicado: (2019) -
Antifungal Efficacy of Redox-Active Natamycin against Some Foodborne Fungi—Comparison with Aspergillus fumigatus
por: Kim, Jong H., et al.
Publicado: (2021) -
Repurposing Clinically Approved Drugs
for the Treatment of Bacillus cereus, a Surrogate for Bacillus anthracis
por: Amakawa, Masami, et al.
Publicado: (2020) -
Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review
por: Friedman, Mendel, et al.
Publicado: (2020)